The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed to those with Type 2 diabetes, it is also used for weight loss.

Ozempic, which accounts for 41% of the company's sales, is an injectable anti-diabetic treatment that became wildly popular ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...

While many use the drugs to manage diabetes and heart disease, about 40% take them for weight loss The reason is simple. Ozempic is the brand name of semaglutide, an anti-diabetic medication for ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

Grapefruit isn’t the only environmental factor affecting how you respond to your medications. Over 8,600 chemicals are used in commerce in the U.S., and you are exposed to thousands of these chemicals ...

Eli Lilly plans to launch Mounjaro, an anti-diabetes and weight loss drug, in India by 2025. The medication, which is ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher.

Embarking on the quest to lose weight can be a risky business. Yo-yo dieting, compulsive binging, muscle wasting and brain ...

The conversation surrounding health care reform has intensified in recent years, revealing deep divides in how we view personal responsibility, government intervention and public health ...